Basic Tumor Immunology Section
Section Editors
Claudia Palena, PhD
National Cancer Institute, National Institutes of Health – United States
Eric Tartour, MD, PhD*
Hôpital Européen Georges Pompidou – France
Associate Editors
Scott I. Abrams, PhD
Roswell Park Comprehensive Cancer Center – United States
Timothy NJ Bullock, PhD*
University of Virginia – United States
Gennaro Ciliberto, MD
IRCCS Istituto Nazionale Tumori Regina Elena – Italy
Khashayarsha Khazaie, PhD, DSc
Mayo Clinic College of Medicine – United States
Michael Platten, MD
Ruprecht-Karls University Heidelberg – Germany
Stefani Spranger, PhD
Massachusetts Institute of Technology – United States
Walter J. Storkus, PhD
University of Pittsburgh – United States
Viktor Umansky, MD, PhD
German Cancer Research Center (DKFZ) – Germany
Case Reports Section
Section Editor
Sebastian Kobold, MD
Klinikum der Universität München – Germany
Associate Editors
Jack D. Bui, MD, PhD
University of California San Diego – United States
Marco Donia, MD, PhD
National Center for Cancer Immune Therapy (CCIT-DK) – Denmark
Heinz Läubli, MD, PhD
University Hospital Basel – Switzerland
Allison Betof Warner, MD, PhD
Stanford Cancer Center – United States
Clinical/Translational Cancer Immunotherapy Section
Section Editors
Jason J. Luke, MD, FACP
UPMC Hillman Cancer Center – United States
Douglas G. McNeel, MD, PhD
University of Wisconsin Carbone Cancer Center – United States
Associate Editors
Paulo Antonio Ascierto, MD
Istituto Nazional Tumori-Fondazione 'G.Pascale' – Italy
Richard D. Carvajal, MD
Northwell Health Cancer Institute – United States
Tina Cascone, MD, PhD
The University of Texas MD Anderson Cancer Center – United States
Tanja D. de Gruijl, PhD
Amsterdam University Medical Centers – Netherlands
Brian R. Gastman, MD
Iovance Biotherapeutics, Inc., – United States
Margaret E. Gatti-Mays, MD, MPH
Ohio State University Comprehensive Cancer Center – United States
Francois Ghiringhelli, PhD
Institut National De La Sante Et De Le Recherche Medicale (INSERM) – France
James J. Harding, MD
Memorial Sloan Kettering Cancer Center – United States
Hongbo Hu, PhD
West China Hospital, Sichuan University – China
Douglas B. Johnson, MD, MSCI*
Vanderbilt University Medical Center – United States
Pawel Kalinski, MD, PhD*
Roswell Park Comprehensive Cancer Center – United States
Yangqiu Li, MD
Jinan University School of Medicine – China
Ravi A. Madan, MD
National Cancer Institute, National Institutes of Health – United States
Luca Mazzarella, MD, PhD
European Institute of Oncology – Italy
Sattva S. Neelapu, MD
The University of Texas MD Anderson Cancer Center – United States
Anna Obenauf, PhD
Research Institute of Molecular Pathology – Austria
Kunle Odunsi, MD, PhD
University of Chicago Medicine Comprehensive Cancer Center – United States
Ravi Patel, MD, PhD
University of Pittsburgh – United States
Alessandro Russo, MD, PhD
Università degli Studi di Messina – Italy
Louis M. Weiner, MD
Georgetown University Lombardi Cancer Center – United States
Commentary/Editorials Section
Section Editor
Christian Capitini, MD
University of Wisconsin, Madison – United States
Associate Editors
Ana Carrizosa Anderson, MD
Harvard University – United States
Diwakar Davar, MD
UPMC Hillman Cancer Center – United States
William J. Murphy, PhD
University of California, Davis – United States
Gabriel Rabinovich, PhD
Instituto de Biologia y Medicina Experimental (IByME) – Argentina
Guidelines and Consensus Statements Section
Section Editor
Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute – United States
Immune Cell Therapies and Immune Cell Engineering Section
Section Editor
Marcela V. Maus, MD, PhD
Massachusetts General Hospital – United States
Deputy Editor
Aude Chapuis, MD
Fred Hutchinson Cancer Research Center – United States
Associate Editors
Marco L. Davila, MD, PhD*
Roswell Park Comprehensive Cancer Center – United States
Joseph A. Fraietta, PhD
University of Pennsylvania – United States
Sara Ghorashian, MD, PhD
University College London – United Kingdom
Jennifer L. Guerriero, PhD
Brigham and Women's Hospital – United States
Michael Hudecek, MD
Universitätsklinikum Würzburg – Germany
Gerald Linette, MD, PhD
University of Pennsylvania – United States
Daniel J. Powell Jr., PhD
University of Pennsylvania – United States
Marco Ruella, MD
University of Pennsylvania – United States
Lillian Seu, PhD
Revolution Medicines – United States
Nirali N. Shah, MD, MHSc
National Cancer Institute, National Institutes of Health – United States
Eric L. Smith, MD, PhD
Dana-Farber Cancer Institute – United States
Maria Themeli, MD, PhD
VUmc Cancer Center Amsterdam – Netherlands
Immunotherapy Biomarkers Section
Section Editors
Ignacio Melero, MD, PhD
Foundation for Applied Medical Research (FIMA) – Spain
Alexandra Snyder Charen, MD
Generate Biomedicines – United States
Deputy Editor
Kurt A. Schalper, MD, PhD
Yale School of Medicine – United States
Associate Editors
Valsamo Anagnostou, MD, PhD
Johns Hopkins University – United States
Maria Ascierto, PhD
AstraZeneca – United States
Carlo B. Bifulco, MD
Providence Portland Medical Center – United States
John C. Castle, PhD
Monte Rosa Therapeutics – Switzerland
Alessandra Cesano, MD, PhD*
ESSA Pharma Inc. – United States
Eric Deutsch, MD, PhD
Gustave Roussy Cancer Campus – France
Elisabeth G.E. de Vries, MD, PhD
University Medical Centre Groningen – Netherlands
Jolanda de Vries, PhD
Radboud University Nijmegen – Netherlands
Michael D. Kalos, PhD*
CTRL Therapeutics – United States
Rejean Lapointe, PhD
Universite De Montreal, University Hospital (CRCHUM) – Canada
Christian H. Ottensmeier, MD, PhD, FRCP
University of Southampton – United Kingdom
Graham P. Pawelec, PhD
University of Tuebingen – Germany
Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale Tumori – Italy
Barbara Seliger, MD, PhD
Martin Luther University Halle-Wittenberg – Germany
Craig L. Slingluff Jr., MD
University of Virginia – United States
Claudio Tripodo, MD
University of Palermo – Italy
Jinada Yuan, MD, PhD
Merck & Co. – United States
Oncolytic and Local Immunotherapy Section
Section Editor
Howard L. Kaufman, MD, FACS
Massachusetts General Hospital – United States
Associate Editors
John C. Bell, PhD
Ottawa Hospital Research Institute – Canada
Kevin Harrington, PhD, FRCP, FRCR
The Institute of Cancer Research – United Kingdom
Samuel Rabkin, PhD*
Massachusetts General Hospital – United States
K. Dane Wittrup, PhD
Massachusetts Institute of Technology – United States
Dmitriy Zamarin, MD, PhD
Icahn School of Medicine at Mount Sinai – United States
Reviews Section
Section Editors
Sandra Demaria, MD
Weill Cornell Medical College – United States
Lawrence Fong, MD
Fred Hutchinson Cancer Center – United States
Associate Editors
Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Care Center – United States
Ira Mellman, PhD
Genentech – United States
James J. Mule, PhD
H. Lee Moffitt Cancer Center – United States
Specialty Editors
Consulting Editor, Special Series and Reviews
Pedro J. Romero, MD
Novigenix – Switzerland
Consulting Editor
Thomas F. Gajewski, MD, PhD
University of Chicago – United States
Social Media Editors
Kristin G. Anderson, PhD
University of Virginia – United States
Praveen Bommareddy, PhD, MS
Replimune, Inc. – United States
Cheng Sun, MD, PhD
University of Science and Technology of China, Hefei – China
*Consulting Reviews Editor